| Company Name: |
Taizhou Crene Biotechnology Co. Ltd.
|
| Tel: |
+86-0576-88813233 +86-13396860566 |
| Email: |
sales@pharm-intermediates.com |
| Products Intro: |
Product Name:CDK9-IN-8
CAS:2105956-51-0
Purity:98% Package:10MG;100MG;500MG;1G
|
CDK9-IN-4d manufacturers
- CDK9-IN-8
-
- $53.00 / 1mg
-
2024-10-28
- CAS:2105956-51-0
- Min. Order:
- Purity: 98.77%
- Supply Ability: 10g
- CDK9-IN-8
-
- $53.00 / 1mg
-
2024-10-24
- CAS:2105956-51-0
- Min. Order:
- Purity: 98.77%
- Supply Ability: 10g
|
| | CDK9-IN-4d Basic information |
| Product Name: | CDK9-IN-4d | | Synonyms: | CDK9-IN-4d;CDK9-IN-8;CDK-9-IN-8,CDK9IN8,CDK9 IN 8;1,1-Cyclopropanedicarboxamide, N-[4-[[7-cyclopentyl-6-[(dimethylamino)carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]phenyl]-N'-(4-fluorophenyl)- | | CAS: | 2105956-51-0 | | MF: | C31H32FN7O3 | | MW: | 569.63 | | EINECS: | | | Product Categories: | | | Mol File: | 2105956-51-0.mol |  |
| | CDK9-IN-4d Chemical Properties |
| density | 1.41±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMSO : 5.2 mg/mL (9.13 mM; ultrasonic and warming and heat to 80°C)| | | pka | 13.86±0.70(Predicted) | | form | Solid | | color | Light yellow to yellow | | Water Solubility | Water : < 0.1 mg/mL (insoluble) |
| | CDK9-IN-4d Usage And Synthesis |
| Biological Activity | CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC50 of 12 nM. | | References | [1]. Li Y, et al. Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3231-3237. |
| | CDK9-IN-4d Preparation Products And Raw materials |
|